Figure 2.

(a) Screening and enrollment process for study. AD Alzheimer’s disease, MCD mild-cognitive disorder, UEF University of Eastern Finland. (b) New data acquired during study. CERAD-NB Consortium to Establish a Registry for Alzheimer’s Disease Neuropsychological Battery, WMS Wechsler Logical Memory Scale, TMT-A/B trail making test parts A and B, CDR clinical dementia rating scale, CDR-SB CDR sum of boxes, ADCS-ADL Alzheimer’s Disease Cooperative Study-Activities of Daily Living scale, TELE telephone assessment for dementia, TICS-m modified telephone interview for cognitive status, Aβ-42/40 amyloid beta (Aβ)1–42/1–40, p-Tau181 phosphorylated-tau181, NfL neurofilament light chain, GFAP glial fibrillary acidic protein;